Delivery Order SPE2DB22D3301-SPE2DB25FY9BW
Award Date 8/8/25
Potential Completion Date 8/29/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a prescription oncology medication used in cancer treatment. The contract, awarded on July 31, 2025, with an ultimate completion date of August 21, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $21,325.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a prescription oncology medication. The award was made on June 17, 2025, with an ultimate completion date of July 10, 2025, and represents a non-competitive delivery order under an existing contract vehicle. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This competitive award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance of this contract will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a prescription oncology medication used to treat certain lung cancers. This firm fixed price delivery order, awarded on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract. The order, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this delivery order as a child contract under a...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tagrisso 80 mg tablets (30-count units) on August 15, 2025, with completion targeted for September 8, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $21,325.14 for 30-count tablets of Tagrisso 80 mg, a prescription medication used in cancer treatment. This competitively awarded, non-set-aside contract features firm fixed pricing and has a completion date of September 23, 2025. The award was issued on September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a prescription oncology medication, with a contract value of $10,662.57. The award, announced on June 18, 2025, with an ultimate completion date of July 11, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a pharmaceutical product for medical supply support. This firm fixed-price delivery order, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency (DLA) awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for Tagrisso 80 mg tablets (30-count supply) under a firm fixed-price contract. The award was issued on September 15, 2025, with an ultimate completion date of October 6, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement to support federal medical supply needs....